List of Vendor Companies in Belgium - 35

Ardena is a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug substance and products for clinical trials. Ardena provides you with an integrated service offering including solid state chemistry, API & nanomedicines development and manufacturing, analytical & formulation development, drug product manufacturing, bioanalytical, drug discovery and dossier development services. Headquartered in Ghent, we have facilities in the Netherlands, Belgium, Sweden and Spain, serving a global customer base, ranging from emerging biotech to tier-one pharmaceutical companies. We understand the complex challenges involved in taking a promising molecule from lab to patient. Each project we undertake is preceded by a detailed planning phase to ensure that the right work is carried out at the right time. This staged approach allows you to stagger your investments and mitigate risks during each phase of the project. Our integrated offering is the engine that drives all of our projects. Our multidisciplinary team is keen to streamline your development process. We also make sure that all the work we do for you is compliant with the appropriate regulatory standards as you move along the clinical development path. Our dossier-centric approach is key to help you compile your regulatory dossier in a timely and cost-efficient manner. By preparing your regulatory dossier in parallel with drug development, we ultimately get your drug to patients faster.

Biocartis is a biotechnology company that specializes in innovative medical devices for precision medicine.

BioLizard is a leading multi-national data analytics and data management consulting company supporting digital transformation in the life sciences industry by offering bespoke, tailored solutions. From data analytics and bioinformatics, to software development and AI, we support biopharma and biotech companies in accessing vital, data-driven insights that can be turned into actions and drive your life sciences research forward. Our team of experienced bioengineers, software engineers and computer science experts combines extensive data science expertise with deep biological knowledge to provide solutions that are tailored to your needs and in line with your unique strategic goals. We have a proven ability to support companies from discovery to pre- & early clinical phases, enabling data-driven R&D. Our expertise spans drug and biomarker discovery and development, in silico screening, target identification, development of companion diagnostics, mechanism-of-action studies, process automation, data strategy, and more. As your true data partner, we’re ready to help you leverage data to keep your competitive edge. Our expert ‘Lizards’ can support you no matter where you are in the world, and in a flexible, proactive, and agile way to drive your data-driven research forward. 𝗥𝗲𝗮𝗰𝗵 𝗼𝘂𝘁 𝘁𝗼 𝗕𝗶𝗼𝗟𝗶𝘇𝗮𝗿𝗱 𝘁𝗼𝗱𝗮𝘆 𝘁𝗼 𝘀𝘁𝗮𝗿𝘁 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝘆𝗼𝘂𝗿 𝗯𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗮𝘁𝗮 𝗶𝗻𝘁𝗼 𝗮𝗰𝘁𝗶𝗼𝗻𝗮𝗯𝗹𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀. More information: https://lizard.bio/home Company video: https://www.youtube.com/watch?v=q9MR126aiNo&t=1s BioLizard careers: https://lizard.bio/careers

Bluesquare technologies promote smarter allocation of resources in emerging economies - so they get to where it matters most. Bluesquare systems and tools boost the reach, quality and efficiency of public services around the world and give users access to key performance data. They allow users to easily collect, manage, structure, visualize and share data. And create a link between financing and results, by transforming traditional aid into data-driven systems - encouraging better stewardship, accountability and transparency of programs. Bluesquare creates value from data and helps people make better decisions. Working with governments, NGOs and donors, Bluesquare's products currently impact over 60 million people in more than 18 countries worldwide. Follow us @blsqhub.

Cell Matters is a company operating in the cell therapy industry that enhances cell therapy productivity through cryopreservation services and GMP compliance.

Cognivia is an innovator of analytical tools to optimize and accelerate the clinical development of new medicines. The privately held company was founded in 2013 by longtime colleagues with decades of experience in the pharmaceutical industry who set out to tackle some of the most challenging issues that prevent drugs from reaching the marketplace. Cognivia helps lessen risk and helps increase clinical trial success. It can help reduce the variability of study data by 30 percent. This can lead to fewer patients needed in a study, equating to less cost and time. The company offers Placebell©™, a solution that improved clinical trial assay sensitivity by characterizing and managing the individual placebo response in a variety of disease states where the placebo effect masks the true efficacy of potentially important therapies.

Founded in 2011, Data Intuitive is a Belgian-based bioinformatics company specialising in data workflow development and deployment. We provide comprehensive data science and bioinformatics services tailored to meet the unique data analysis challenges of our clients. Our expertise ranges from deploying ready-to-run data analysis tools from our catalogue to composing and developing custom workflows tailored to your specific needs. Whether it’s integrating bioinformatics modules, building scalable infrastructure, or benchmarking your computational methods against industry standards, we provide comprehensive support every step of the way. Together with the upcoming Viash Hub platform, this forms a long-term, future-proof strategy for data workflow development, empowering clients to customise and optimise workflows for their specific needs. Our innovative tool Viash streamlines the creation of data workflow modules by generating boilerplate code to tackle key challenges in workflow development, such as scalability, reproducibility, and ease of use. These modular components are easy to incorporate into existing environments, ensuring efficiency, consistency, and scalability across projects. By partnering with Data Intuitive, top-tier pharmaceutical R&D teams and other clients gain access to cutting-edge bioinformatics solutions that drive innovation, foster growth, and ensure the continuous success of their data workflows.

Our mission is to enhance access to medical treatment by delivering excellence in the design and execution of clinical trials. DICE is a Contract Research Organization with over 30 years of experience in the execution of clinical trials. We have assisted in the execution of Phase I-IV studies and supported in the defense at EMA and FDA with clients from across the globe. We have expertise in an array of therapeutic areas and experience in the development of different medical technologies. DICE offers a variety of services including: Clinical Study Design, Clinical Data Management, Biostatistical Analysis, Medical Writing, Central Imaging Review, and Medical Monitoring. Our knowledgeable and dedicated team of experts have a drive and curiosity that encourages them to take on projects as if they were their own. At DICE, your success is our own success. For more information, visit www.dice-cro.com

Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all. As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing. Company number: 0744643660 VAT: BE0744643660

FLUIDDA’s main acitivities consist of developing imaging biomarkers to enhance drug development and patient care. These biomarkers combine biomedical imaging and advanced engineering methods. It has been demonstrated in recent studies that this novel approach yields sensitive outcome parameters to detect physiological or clinical changes in patients following an intervention. This provides additional insight into the mode of action of the intervention and allows for optimization of the therapy and improved patient selection. To support the implementation of this novel method into clinical studies and clinical practice, FLUIDDA also offers a CRO service with the focus on imaging. A complete package can therefore be offered to the client from initial protocol writing to full data analysis using the advanced processing techniques. To offer a high quality service FLUIDDA employs experts in all required fields from medical doctors to biomedical scientists and engineers. #FRI #FunctionalRespiratoryImaging

Formac Pharma is a pharmaceutical company that specializes in developing best in class new pharmaceutical products using silica-based drug delivery platforms to improve the performance of poorly soluble compounds, while also partnering with pharmaceutical and animal health companies.

Fujirebio is a global leader in the field of high-quality in vitro diagnostics (IVD). We are an R&D-driven company constantly developing new technologies and unique biomarkers with high clinical value. Our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care. Our global teams located in Japan, Asia, Europe and the US focus on delivering products with the highest quality standards to our customers and partners. We value partnerships with other leading companies in the industry, sharing knowledge, capabilities, and critical materials in order to supply, develop or manufacture diagnostic solutions on a wide variety of platforms. Through this business model, we ensure that the potentially life-changing diagnostic markers meet the largest global need in the shortest possible time. Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states. Its IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions. Founded in 1950 in Tokyo, Japan, Fujirebio has over the years concluded a number of successful acquisitions of best-in-class IVD companies. Examples include Centocor Diagnostics in 1998, CanAg Diagnostics in 2006 and Innogenetics in 2010. Today, Fujirebio’s global presence includes offices in the United States, Latin America, Europe and Asia as well as a vast international distribution network. Fujirebio is today a consolidated subsidiary of H.U. Group Holdings, Inc. (listed on the Tokyo Stock Exchange – TYO: 4544) and employs more than 1,200 people in Asia, Europe and America.

Gabi SmartCare offers an all-in-one system for home-based pediatric care, tailored to your organization's needs. Our platform simplifies screening, diagnosis, and management of pediatric conditions, supporting healthcare providers in delivering optimal care and providing peace of mind to parents.

Provides Direct-to-Consumer testing and analysis services.

Huvepharma is a fast growing global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products. The company also manufactures and markets enzymes for food, feed and industrial applications. Huvepharma is a privately owned company headquartered in Sofia, Bulgaria.

IDS is a global medical diagnostics business dedicated to the development and provision of innovative automated and manual assays. Our development focus is in the clinical areas of bone and calcium metabolism, growth, hypertension and chronic kidney disease. Our IDS-iSYS system is designed with the flexibility to accommodate unique and challenging requirements, the IDS-iSYS automation brings testing efficiency and uncompromised quality to specialty immunoassay testing. IDS provides a compact bench top system that fully automates immunoassay testing. IDS has its global headquarters in the UK and has subsidiaries in Germany, France, Belgium, Italy and Nordic countries. Other markets, including key diagnostic markets of Spain, Australia, Japan are serviced by a network of highly qualified and experienced distributors within each territory.

miDiagnostics is using silicon chip technology which will bring miniaturized, rapid, easy-to-use, lab-quality tests with built-in connectivity direct to the patient and clinician. Combining a nanofluidic processor on a chip and a compact reader, miDiagnostics can measure virtually any biomarker from an easily accessed sample. The Company is developing an extensive portfolio of tests for screening, diagnosis and monitoring of a wide range of health conditions, including infectious diseases. Spun out of the world-leading R&D and innovation hub in nanoelectronics and digital technologies, imec, and a research collaboration with Johns Hopkins University, the leading US research and medical centre, miDiagnostics' goal is to enable fast, comprehensive and cost-effective health analysis, regardless of location. Based in Leuven, Belgium, miDiagnostics is a privately held company created in 2015.

MyCellHub.com - Digital GMP workflows MyCellHub provides a toolkit for the digitalisation, data integration and data analytics of regulated laboratory and cleanroom workflows. More than 90% of biotech and (bio)pharmaceutical companies currently create production reports on paper. It's time to accelerate the launch of new therapies and not be held back anymore by paperwork.

Ncardia's hiPSC products portfolio encompasses a broad panel of cardiovascular and neural cells. In addition, the company delivers the Cardioplate™ product line of quality-controlled ready-to-use assay plates.

N-SIDE is a world leader in increasing the efficiency of life sciences and energy industries by providing software and services that optimize the use of natural resources, facilitating the transition to a more sustainable world. To achieve this, N-SIDE leverages its deep industry knowledge, technical expertise, and understanding of applied mathematics to help global pharmaceutical and energy companies anticipate, adapt, and optimize their decisions. In the life sciences industry, N-SIDE reduces waste in clinical trials, leading to more efficient, faster, and more sustainable clinical trials. In the energy industry, N-SIDE helps electricity market and grid operators in enabling a safer and faster transition toward renewable sources. N-SIDE is driven by a diverse team of over 200 passionate engineers, computer scientists, and business experts from 30+ different nationalities, including individuals with advanced academic qualifications such as PhDs. Together, they are committed to making a meaningful impact toward a more sustainable future. N-SIDE is headquartered in Belgium with offices in the USA and Japan. The company is certified B Corporation, Best Managed Company by Deloitte Belgium, ISO 14001 and ISO 27001.

OHMX.Bio provides a complete R&D platform to help customers resolve their biological questions through cutting-edge technologies in different -omics fields: (epi)genomics, transcriptomics, translatomics and proteomics. Current flagships in portfolio are ribosome profiling and third generation sequencing. With its in-house developed high performant ribosome profiling service, OHMX.bio provides a genome-wide assessment of mRNA targeted by translating ribosomes. This highly sensitive sequencing-based technology unravels the translatome, a snapshot of RNA that is being translated. Quantification of gene-specific translation, discovery of non-canonical translation events, investigation of ribosome elongation speed and pausing, figuring out translation regulation by microRNAs and RNA-binding proteins and/or determination of mechanisms related to translation initiation and termination, are made possible. OHMX.bio also services third generation sequencing workflows based on the Oxford Nanopore Technology. Direct DNA and RNA solutions allow for amplification-free sequencing of (ultra-)long reads and additionally allow to map their epigenetic features. Applications are everywhere, in the fields of clinical and more specifically cancer research, environmental and plant research, microbiology and microbiome analysis, genome and transcriptome research.

OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group of companies with world-renowned expertise. The Group offers a unique portfolio that combines NGS services, biomarker testing, data interpretation software, and clinical decision support tools. OncoDNA is headquartered in Belgium, and its entities – Biosequence and IntegraGen – are based in Spain, France and the United States. The Group employs over 100 employees across 9 countries, works with an international network of 35 distributors and collaborates with both European-based and US-based subcontracted accredited laboratories.

Ovizio Imaging Systems, founded in 2009, is a Belgian company that provides the bioprocessing industry with a unique PAT for gathering insight into their cell culture process. The Ovizio platform utilizes label-free, non-destructive, holographic microscopy to detect changes in cell morphology, which is recorded by the microscope and interpreted by AI into meaningful data. The bio-connect, a single-use disposable, allows for closed-loop travel of the cells between the bioreactor and the instrument for analysis. Some applications of interest include cell density and viability metrics, cell counting of cells on microcarriers, transduction or transfection efficiency, cell subtype differentiation, cell activation, and early stage bacterial or fungi contamination. Ovizio’s flagship instrument, the iLineF Pro, is GMP qualified and is commonly used in the cell & gene therapy industry where it is deployed in manufacturing, as well as process development.

4Clinics is a Contract Research Organization (CRO) providing Data management, Biostatistics, Scientific Writing, Regulatory Affairs and Clinical Operations services for clinical and epidemiological studies with a particular expertise in vaccines, immunology, immuno-oncology and medical devices. 4Clinics serves pharmaceutical, biotechnology and medical devices companies as well as NGOs, hospitals and researchers with tailor-made services including remote biometry and medical writing platforms. 4Clinics has offices in Belgium, France and Morocco and has a global coverage. For more information, please visit www.4Clinics.com

PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera's ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general.

Meat has been on our menu for cen­tur­ies. With good reas­on, cause it's nutri­tious and damn deli­cious. Sadly, the story behind today's mass-pro­duced meat is less savoury. The plan­et and anim­als need a break … but the glob­al demand for meat keeps rising. It's time to rethink our meat for tomor­row.

reMYND NV is a dynamic biotech company located in Leuven (Belgium) that actively drives R&D in the field of protein misfolding diseases, among others Alzheimer's disease (AD) and Parkinson's disease (PD). The company consists of two independently managed units. The Drug Discovery and Development Unit focuses on disease-modifying treatments for among others AD and PD (counteracting TAU and aSyn toxicity, respectively). The Contract Research Unit offers extensive experience in the testing of experimental Alzheimer therapies in its unique and proprietary transgenic mouse models. For more information please visit www.remynd.com Alternatively, please contact Koen De Witte (Managing Director - pipeline@remynd.com) to hear more about reMYND's pipeline or Bart Roucourt (Manager Contact Research - cro@remynd.com) to get more information on reMYND's Contract Research Offering.

S-Biomedic is a life science company focused on skin health by pioneering the development of Pro- and Post-biotic ingredients from true skin commensals. S-Biomedic delivers: • novel active ingredients for use in cosmetic formulations • unique positioning & skin benefits • clinically substantiated efficacy claims S-Biomedic is changing the paradigm in skincare and dermatology by unleashing the natural power of your skin microbiome capitalizing on its breakthrough proprietary technology platform and expertise to deliver novel solutions for a wide variety of skin conditions. S-Biomedic is changing the paradigm in skincare and dermatology by unleashing the natural power of your skin microbiome capitalizing on its breakthrough proprietary technology platform and expertise to deliver novel solutions for a wide variety of skin conditions.

Sillar Clinical provides solutions ranging from consultancy and the design, over the set-up, to the full management of clinical development projects. Our customers are biotech, medtech, academic institutions and pharmaceutical companies. Great minds think alike. To unlock your innovations in medical science and to address your unmet needs at any time, we stay ahead of new regulations in clinical development. We help you thrive via our agile step by step approach. Smart transition from preclinical to clinical. - We simplify the complex of clinical operations for new therapies and technologies. - We think with you by putting pragmatism, creativity and tailor-made solutions at the core of what we do. - We guide you to bring your new medical advances to patients. - We offer a multitalented team to co-create your tasks with the highest level of effectivity and output quality.

Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a "Startup in the Labs", meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. Syngulon offers a new selection technology focused on the control of microorganismal growth. This technology is based on the use of bacteriocin/immunity in any bacteria, yeast or algae for controlled growth of microorganisms (US Patent 9,333,227/10,188,114). Syngulon has demonstrated its selection technology's efficacy at lab scale and is working with customers to use this technology for the production of recombinant products (application in sterile condition). For application in open or semi-open fermentor, Syngulon can customize the bacteriocins based on metagenomic analysis of contaminants.

tebu-bio runs a wide variety ofin vitroassays, in addition to providing specialty reagentsLocated in eight European countries.

UgenTec is a molecular laboratory software provider servicing molecular labs, assay and instrument providers globally across applications in Clinical Molecular Diagnostics, Veterinary health, Crop Science, Breeding and Seed Health. UgenTec is headquartered in Hasselt, Belgium with offices in Boston, MA and its FastFinder platform has a global installed base of over 100 molecular labs and partnerships with leading molecular diagnostics vendors. FastFinder is a modular, clinical grade Software as a Service platform using AI methods allowing labs of all sizes to standardize and automate their molecular workflows. FastFinder’s modules include Analysis, Genotyper and Workflow.

For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit.

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering billions of components and devices each year. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index.

About YUN YUN is building a new era of personal care, based on everyone's natural strength. YUN does this based on good bacteria which protect, strengthen and repair the skin's natural protective layer. To do so, YUN has developed effective solutions for common skin conditions and personal care. This is how YUN helps its users to feel better in their own skin. YUN Probiotherapy is a revolutionary new solution for common skin conditions and personal care. YUN develops innovative creams and sprays based on good, live bacteria that repair the skin flora. In addition to products based on live probiotics, YUN also develops soaps and creams that consist of soft ingredients that protect and strengthen the skin flora.